What should you know about met targeted therapy?

MET is involved in signals that can tell cells to grow, move or survive. Some cancers develop changes that make this pathway unusually active. A targeted medicine is chosen to block a particular signal or protein, rather than treating every cell in the same way.

The term MET-targeted therapy does not mean one single drug or one plan. Doctors consider the exact alteration, cancer type, previous treatment, organ function, other medicines and symptoms. MET changes may be assessed in cancers such as lung cancer and other tumour types, but testing is needed before linking a treatment to a person.

Ask whether genomic tumour profiling has identified a MET alteration and request an explanation of the result in plain language. Tell the team about all medicines, supplements and existing liver, kidney or heart problems. Follow instructions about dosing and monitoring, and keep a daily note of symptoms.

Possible effects depend on the medicine and may involve appetite, digestion, swelling, tiredness, skin, vision or liver tests. Report changes early rather than stopping treatment without advice. If the medicine no longer controls the cancer or causes difficult effects, the team can discuss another approach, including treatment for symptoms.

Get urgent medical help for severe breathlessness, chest pain, fainting, confusion, sudden weakness, facial swelling or a serious allergic reaction. Contact the treatment team promptly for yellowing of the skin, dark urine, persistent vomiting, severe diarrhoea, significant swelling, new vision problems or fever.

Ask: What MET change was found, and how reliable is the result? How is the medicine taken? Which blood tests or scans are needed? Which side effects require same-day advice? What happens if the cancer stops responding or the medicine is not suitable?